​

Revvity (RVTY) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

RVTY Stock Forecast

Revvity (RVTY) stock forecast, based on 29 Wall Street analysts, predicts a 12-month average price target of $115.14, with a high of $129.00 and a low of $105.00. This represents a 28.46% increase from the last price of $89.63.

$85 $94 $103 $112 $121 $130 High: $129 Avg: $115.14 Low: $105 Last Closed Price: $89.63

RVTY Stock Rating

Revvity stock's rating consensus is Buy, based on 29 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (58.62%), 12 Hold (41.38%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 29 0 12 17 Strong Sell Sell Hold Buy Strong Buy

RVTY Price Target Upside V Benchmarks

TypeNameUpside
StockRevvity28.46%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks30.02%

Price Target Trends

1M3M12M
# Anlaysts-713
Avg Price Target-$116.57$113.77
Last Closing Price$89.63$89.63$89.63
Upside/Downside-30.06%26.93%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26388--19
Feb, 26389--20
Jan, 26388--19
Dec, 25396--18
Nov, 25396--18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 03, 2026Catherine Ramsey SchulteRobert W. Baird$129.00$103.8924.17%43.93%
Feb 03, 2026Cowen & Co.$124.00$106.9715.92%38.35%
Feb 03, 2026Evercore ISI$118.00$107.0910.19%31.65%
Feb 03, 2026Barclays$118.00$107.0910.19%31.65%
Feb 02, 2026Jefferies$105.00$107.05-1.91%17.15%
Dec 15, 2025Brandon CouillardWells Fargo$107.00$100.466.51%19.38%
Dec 15, 2025Luke SergottBarclays$115.00$100.4614.47%28.31%
Dec 09, 2025Evie KosloskyGoldman Sachs$105.00$99.795.22%17.15%
Oct 28, 2025Robert W. Baird$123.00$97.7425.84%37.23%
Oct 28, 2025Barclays$105.00$97.168.07%17.15%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 03, 2026Cowen & Co.HoldHoldhold
Feb 03, 2026Cowen & Co.BuyBuyhold
Feb 03, 2026Evercore ISIOutperformOutperformhold
Feb 03, 2026BarclaysOverweightOverweighthold
Feb 02, 2026JefferiesHoldHoldhold
Jan 05, 2026Evercore ISIOutperformOutperformhold
Dec 15, 2025BarclaysOverweightOverweighthold
Dec 09, 2025Goldman SachsNeutralinitialise
Oct 28, 2025BarclaysOverweightOverweighthold
Oct 27, 2025Evercore ISIOutperformOutperformhold

Financial Forecast

EPS Forecast

$-5 $-1 $3 $7 $11 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.12$4.51$-0.95$2.41$2.08---
Avg Forecast$11.04$7.78$4.56$4.85$4.98$5.59$6.21$6.64
High Forecast$11.12$7.86$4.59$4.87$5.18$5.91$6.32$6.76
Low Forecast$10.90$7.63$4.54$4.79$4.87$4.91$6.12$6.54
Surprise %-26.45%-42.03%-120.83%-50.31%-58.23%---

Revenue Forecast

$3B $3B $4B $4B $5B $6B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.83B$3.31B$2.75B$2.76B$2.86B---
Avg Forecast$4.98B$4.59B$2.73B$2.75B$2.86B$3.05B$3.23B$3.30B
High Forecast$5.00B$4.63B$2.74B$2.79B$2.89B$3.06B$3.25B$3.34B
Low Forecast$4.93B$4.52B$2.70B$2.74B$2.83B$3.04B$3.21B$3.26B
Surprise %-23.08%-27.83%0.68%0.04%-0.15%---

Net Income Forecast

$-500M $-100M $300M $700M $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$943.16M$569.18M$-118.38M$295.83M$241.68M---
Avg Forecast$1.38B$971.53M$569.72M$602.42M$627.36M$675.00M$776.55M$828.50M
High Forecast$1.39B$981.56M$572.85M$607.42M$646.75M$737.60M$789.41M$843.15M
Low Forecast$1.36B$952.74M$566.60M$597.43M$607.97M$612.39M$763.68M$815.67M
Surprise %-31.54%-41.41%-120.78%-50.89%-61.48%---

RVTY Forecast FAQ

Is Revvity stock a buy?

Revvity stock has a consensus rating of Buy, based on 29 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 12 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Revvity is a favorable investment for most analysts.

What is Revvity's price target?

Revvity's price target, set by 29 Wall Street analysts, averages $115.14 over the next 12 months. The price target range spans from $105 at the low end to $129 at the high end, suggesting a potential 28.46% change from the previous closing price of $89.63.

How does Revvity stock forecast compare to its benchmarks?

Revvity's stock forecast shows a 28.46% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the diagnostics & research stocks industry (30.02%).

What is the breakdown of analyst ratings for Revvity over the past three months?

  • March 2026: 15.79% Strong Buy, 42.11% Buy, 42.11% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 15.00% Strong Buy, 40.00% Buy, 45.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 15.79% Strong Buy, 42.11% Buy, 42.11% Hold, 0% Sell, 0% Strong Sell.

What is Revvity’s EPS forecast?

Revvity's average annual EPS forecast for its fiscal year ending in December 2026 is $5.59, marking a 168.75% increase from the reported $2.08 in 2025. Estimates for the following years are $6.21 in 2027, and $6.64 in 2028.

What is Revvity’s revenue forecast?

Revvity's average annual revenue forecast for its fiscal year ending in December 2026 is $3.05B, reflecting a 6.91% increase from the reported $2.86B in 2025. The forecast for 2027 is $3.23B, and $3.3B for 2028.

What is Revvity’s net income forecast?

Revvity's net income forecast for the fiscal year ending in December 2026 stands at $675M, representing an 179.30% increase from the reported $241.68M in 2025. Projections indicate $776.55M in 2027, and $828.5M in 2028.